lobbying_activities: 2596186
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2596186 | 05b057f0-c693-49bc-a7be-93bf20f1a6e9 | Q1 | RUBICON ADVISORS, LLC | 315091 | DYNAVAX TECHNOLOGIES | 2021 | first_quarter | PHA | Prescription Drug User Fee, Biomedical Advance Research and Development Authority (BARDA) | HOUSE OF REPRESENTATIVES,SENATE | 75000 | 0 | 0 | 2021-04-15T12:37:32.237000-04:00 |